Clinical Trials on Resistance Training

Total 6112 results

Andrea Roe, MD, MPH

Recruiting

Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS (RING-PCOS)

Polycystic Ovary Syndrome

United States
Oregon Health and Science University

Completed

Fatty Acid Oxidation Defects and Insulin Sensitivity

Normal Volunteers | Trifunctional Protein Deficiency | Very Long-chain Acyl-CoA Dehydrogenase Deficiency | Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency | Medium-chain Acyl-CoA Dehydrogenase Deficiency | Carnitine Palmitoyltransferase II Deficiency, Myopathic

United States
Seoul National University Boramae Hospital

Completed

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

Fatty Liver | Chronic Hepatitis B | Hepatic Fibrosis

Korea, Republic of
Helsinki University Central Hospital
Merck Sharp & Dohme LLC

Completed

Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir (OBERAL)

Fatty Liver | Metabolic Syndrome | HIV Seropositivity

Finland
National Heart, Lung, and Blood Institute (NHLBI)

Completed

VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypertension | Obesity | Diabetes Mellitus | Insulin Resistance | Carotid Artery Diseases | Diabetes Mellitus, Non-insulin Dependent
National Institute on Aging (NIA)
University of Pittsburgh

Unknown

Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress

Obstructive Sleep Apnea | Metabolic Syndrome X

United States
MacroGenics

Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

Melanoma | Sarcoma | Clear Cell Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Advanced Solid Tumor | Endometrial Cancer | Small-cell Lung Cancer | Advanced... and other conditions

United States, Australia
National Cancer Institute (NCI)
NRG Oncology

Withdrawn

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditions

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Progenics Pharmaceuticals, Inc.

Not yet recruiting

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Prostate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate Cancer

United States
Blue Earth Therapeutics Ltd
PSI CRO

Recruiting

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Urogenital Neoplasms | Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPC

United States, Netherlands
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bayer

Recruiting

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD)

Prostate Adenocarcinoma | Metastatic Prostate Adenocarcinoma | Castration-resistant

United States, Brazil
Suzhou Kintor Pharmaceutical Inc,

Completed

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)

United States
Sandy Srinivas
Wyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaborators

Terminated

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate Cancer

United States
Prism Health North Texas
Merck Sharp & Dohme LLC

Withdrawn

Doravirine and Weight Gain in Antiretroviral Naive (DAWN)

Obesity | Metabolic Syndrome | Body Weight Changes | Human Immunodeficiency Virus | Fasting | Minority Health | ART | BMD

United States
Hospital Universitario Reina Sofia de Cordoba

Completed

CORonary Diet Intervention With Olive Oil and Cardiovascular PREVention (CORDIOPREV)

Myocardial Infarction | Diabetes Mellitus | Metabolic Syndrome | Cognitive Decline | Unstable Angina | Malignancy

Spain
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; National... and other collaborators

Completed

Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma (METSLIVER)

Hepatocellular Carcinoma | Metabolic Syndrome | Morbid Obesity | Cholangiocarcinoma | Vertical Sleeve Gastrectomy | Disorder of Bile Acid and Cholesterol Metabolism

France
University Hospitals Cleveland Medical Center

Completed

Study of Vitamin D and Effect on Heart Disease and Insulin Resistance

HIV Infections | Vitamin D Deficiency | Human Immunodeficiency Virus (HIV)

United States
University of California, San Francisco
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Not yet recruiting

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Castration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IVB Prostate Cancer AJCC v8

United States
National Cancer Institute (NCI)

Suspended

Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma

United States
Roswell Park Cancer Institute
Active Biotech AB

Completed

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate Cancer

United States
University of California, Los Angeles

Withdrawn

Postoperative Antibiotics Following Primary and Secondary Breast Augmentation

Surgical Site Infection | Antibiotic Side Effect | Antibiotic Resistant Infection | Capsular Contracture Associated With Breast Implant
University of Washington
National Cancer Institute (NCI)

Completed

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Hormone-Resistant Prostate Cancer | Stage IV Prostate Adenocarcinoma

United States
GenoSaber
Sun Yat-sen University; Shanghai Chest Hospital; Shanghai Pulmonary Hospital,...

Unknown

Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)

Non Small Cell Lung Cancer | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation
IRCCS Eugenio Medea

Recruiting

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

Epilepsy | Angelman Syndrome | Dup15q Syndrome

Italy
Alliance Foundation Trials, LLC.
Bayer

Recruiting

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide (ARACOG)

Prostate Cancer | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Castrate Resistant Prostate Cancer

United States
Karolinska Institutet
The Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaborators

Recruiting

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer (ProBio)

Metastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Sweden, Belgium, Switzerland, Norway
University of Chicago
NorthShore University HealthSystem

Completed

Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

Recurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate Cancer

United States
Stanford University

Terminated

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Prostatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate Cancer

United States
TILT Biotherapeutics Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditions

United States, Finland
National Cancer Institute (NCI)

Completed

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Recurrent... and other conditions

United States
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Behavioral Economics for Activity Motivation in Adolescents (BEAM)

Polycystic Ovary Syndrome | Insulin Resistance | PreDiabetes | Type 2 Diabetes

United States
Near East University, Turkey

Completed

Myoinositol Treatment and Asprosin Levels in PCOS

Insulin Resistance | PCOS

Cyprus
Laval University

Completed

Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans

Overweight | Metabolic Syndrome | Insulin Resistance | Endotoxemia | Non-Alcoholic Fatty Liver Disease | Microtia

Canada
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brigham... and other collaborators

Completed

Shift Work, Heredity, Insulin, and Food Timing Study (SHIFT)

Diabetes Mellitus, Type 2 | Insulin Resistance | Circadian Rhythm Sleep Disorder, Shift Work Type | Shift Work Type Circadian Rhythm Sleep Disorder

United States
Louisiana State University Health Sciences Center...

Completed

Asthma and Obesity Diet Versus Exercise

Physical Activity | Metabolic Syndrome | Inflammatory Response | Asthma in Children | Obesity, Childhood | Nutrition Poor | Behavior, Eating | Maternal Exposure | Molecular Biology, Restriction Fragment Length Polymorphisms | Genetic Change

United States
Universidad de Guanajuato

Completed

Frequency of Metabolic Syndrome in Down Syndrome Patients

Down Syndrome | Metabolic Syndrome X

Mexico
John Sievenpiper
Canadian Institutes of Health Research (CIHR); Canada Research Chairs Endowment... and other collaborators

Unknown

Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease

Hypertension | Obesity | Cardiovascular Disease | Diabetes | Overweight | Metabolic Syndrome | Dyslipidemia | Coronary Heart Disease | Hyperlipidemia | Prediabetes | Gout | Dysglycemia

Canada
University of Erlangen-Nürnberg Medical School
Siemens-Betriebskrankenkasse

Terminated

Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause

Coronary Disease | Bone Diseases | Metabolic Syndrome X

Germany
The University of Hong Kong

Terminated

Endothelial Damage and Atherosclerosis in Obstructive Sleep Apnea

Insulin Resistance | Obstructive Sleep Apnea | Oxidative Stress | Endothelial Function

Hong Kong
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC)

Metastasis Castration Resistant Prostate Cancer(mCRPC)

China
Vestre Viken Hospital Trust
University of Bergen; Haukeland University Hospital

Recruiting

Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway (HVAPNOR)

Infectious Disease | Hospital-acquired Pneumonia | Pneumonia, Ventilator-Associated | Antibiotic Resistant Infection | Infection, Hospital

Norway
University of Washington
National Cancer Institute (NCI); AstraZeneca

Completed

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma

United States
Research Center Borstel
Ludwig-Maximilians - University of Munich

Terminated

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Bacterial Infections | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Mycobacterial Infection

Germany, Moldova, Republic of, Romania, Ukraine
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide (UPWARD)

Metastatic Castration-resistant Prostate Cancer (mCRPC)

France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
Jonsson Comprehensive Cancer Center
Novartis; Stand Up To Cancer; Prostate Cancer Foundation

Active, not recruiting

Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer

Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni Foundation

Terminated

Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Hormone-Resistant Prostate Cancer

United States
University Hospital, Strasbourg, France

Unknown

Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia (SPREAD)

Focal Epilepsy | Refractory Epilepsy | Focal Cortical Dysplasia

France
University of Turin, Italy

Recruiting

Prospective Study on Primary Aldosteronism in Resistant Hypertension (PrePARe)

Atrial Fibrillation | Primary Aldosteronism | Resistant Hypertension | Refractory Hypertension | Hypertensive End-Organ Damage | Aortic Ectasia

Italy
Pfizer

Completed

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Metastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Finland
University of Southern California
National Cancer Institute (NCI); Mayo Clinic

Active, not recruiting

Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

Breast Cancer | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer

United States

Clinical Trials on Resistance Training

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations